Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Hemoptysis and Menorrhagia.

Western journal of medicine and surgery·2024
Same author

Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.

The journals of gerontology. Series A, Biological sciences and medical sciences·2010
Same author

Design of aging intervention studies: the NIA interventions testing program.

Age (Dordrecht, Netherlands)·2009
Same author

Genetic regulation of hematopoietic stem cell exhaustion during development and growth.

Experimental hematology·2005
Same author

Genetic variability in responses to caloric restriction in animals and in regulation of metabolism and obesity in humans.

The journals of gerontology. Series A, Biological sciences and medical sciences·2002
Same author

Heritability of life span in mice and its implication for direct and indirect selection for longevity.

Genetica·2002

Related Experiment Video

Updated: Jul 2, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Hematopoietic stem cell functional failure in interleukin-2-deficient mice.

J Chen1, C M Astle, D E Harrison

  • 1Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892-1652, USA. chenji@nhlbi.nih.gov

Journal of Hematotherapy & Stem Cell Research
|February 20, 2003
PubMed
Summary

Interleukin-2 (IL-2) deficiency causes hematological failure and autoimmune responses in mice. Despite normal proliferation, hematopoietic stem cells (HSCs) from IL-2 deficient mice are functionally defective in repopulating blood cell lineages.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jul 2, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

  • Immunology
  • Hematology
  • Stem Cell Biology

Background:

  • Interleukin-2 (IL-2) is crucial for lymphocyte development and function.
  • IL-2 deficiency is known to cause severe immunodeficiency and autoimmune diseases.
  • The impact of IL-2 deficiency on hematopoiesis, particularly on hematopoietic stem cells (HSCs), requires further investigation.

Purpose of the Study:

  • To investigate the effects of interleukin-2 (IL-2) deficiency on hematopoiesis.
  • To assess the function of hematopoietic stem cells (HSCs) in IL-2 deficient mice.

Main Methods:

  • Gene-targeted Il2 null (Il2(-/-)) mice and wild-type (Il2(+/+)) littermates were used.
  • Cellular compositions in peripheral blood, spleen, thymus, and bone marrow were analyzed using Advia 120 Hematology system and fluorescence-activated cell staining (FACS).
  • Long-term HSC function was evaluated in vivo using competitive repopulation assays.

Main Results:

  • Il2(-/-) mice exhibited hematological failure, including anemia, lymphocytopenia, and thrombocytopenia, along with splenomegaly and thymus involution.
  • Bone marrow cells (BMCs) from Il2(-/-) mice showed normal cell numbers but contained increased populations of HSC and progenitor cells.
  • Competitive repopulation assays revealed a 10- to 20-fold reduction in HSC repopulating ability in Il2(-/-) mice, affecting both myeloid and lymphoid lineages.

Conclusions:

  • IL-2 deficiency leads to functional defects in hematopoietic stem cells (HSCs), despite normal proliferation capacity.
  • These HSC defects contribute to the observed hematological failure and autoimmune responses in Il2(-/-) mice.
  • IL-2 plays a critical role in maintaining HSC function essential for long-term hematopoiesis.